Filter News
Area of Research
- (-) Biology and Environment (11)
- Clean Energy (13)
- Computational Engineering (1)
- Fusion and Fission (5)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (4)
- Materials (14)
- Materials for Computing (2)
- National Security (3)
- Neutron Science (6)
- Nuclear Science and Technology (6)
- Supercomputing (19)
News Topics
- (-) Advanced Reactors (1)
- (-) Biomedical (9)
- (-) Critical Materials (1)
- 3-D Printing/Advanced Manufacturing (7)
- Artificial Intelligence (3)
- Big Data (2)
- Bioenergy (19)
- Biology (34)
- Biotechnology (7)
- Buildings (2)
- Chemical Sciences (11)
- Clean Water (4)
- Climate Change (13)
- Composites (4)
- Computer Science (7)
- Coronavirus (9)
- Cybersecurity (1)
- Decarbonization (6)
- Energy Storage (6)
- Environment (36)
- Exascale Computing (1)
- Fusion (1)
- Grid (1)
- High-Performance Computing (10)
- Hydropower (2)
- Isotopes (2)
- Machine Learning (3)
- Materials (11)
- Materials Science (6)
- Mathematics (2)
- Mercury (3)
- Microscopy (7)
- Molten Salt (1)
- Nanotechnology (5)
- National Security (1)
- Net Zero (2)
- Neutron Science (3)
- Nuclear Energy (1)
- Partnerships (5)
- Physics (2)
- Polymers (2)
- Security (1)
- Simulation (7)
- Summit (4)
- Sustainable Energy (10)
- Transformational Challenge Reactor (1)
- Transportation (2)
Media Contacts
![ORNL scientists developed a method that improves the accuracy of the CRISPR Cas9 gene editing tool used to modify microbes for renewable fuels and chemicals production. This research draws on the lab’s expertise in quantum biology, artificial intelligence and synthetic biology. Credit: Philip Gray/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2023-11/CRISPR%20Quantum%20AI_2_23-G07105-DOE-BER-BESSD-comms-graphic-pcg_2.jpg?h=847b7ff0&itok=WD2dBsAC)
Scientists at ORNL used their expertise in quantum biology, artificial intelligence and bioengineering to improve how CRISPR Cas9 genome editing tools work on organisms like microbes that can be modified to produce renewable fuels and chemicals.
![TIP graphic](/sites/default/files/styles/list_page_thumbnail/public/2023-06/TIPbg_1200.png?h=da33fe38&itok=y7ggwHLV)
Scientist-inventors from ORNL will present seven new technologies during the Technology Innovation Showcase on Friday, July 14, from 8 a.m.–4 p.m. at the Joint Institute for Computational Sciences on ORNL’s campus.
![Seven scientists at the Department of Energy’s Oak Ridge National Laboratory have been named Battelle Distinguished Inventors, in recognition of their obtaining 14 or more patents during their careers at the lab. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2022-12/InventorWinners_0.png?h=b6717701&itok=MO7KGBMz)
Seven scientists at the Department of Energy’s Oak Ridge National Laboratory have been named Battelle Distinguished Inventors, in recognition of their obtaining 14 or more patents during their careers at the lab.
![ORNL’s Tomás Rush explores the secret lives of fungi and plants for insights into the interactions that determine plant health. Credit: Genevieve Martin/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2022-10/Tomas%20Thumbnail.png?h=c6980913&itok=lhmIQFW4)
Tomás Rush began studying the mysteries of fungi in fifth grade and spent his college intern days tromping through forests, swamps and agricultural lands searching for signs of fungal plant pathogens causing disease on host plants.
![MDF Exterior](/sites/default/files/styles/list_page_thumbnail/public/2022-06/2021-p07609.jpg?h=be3e4b3a&itok=YfKK7Wy2)
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
![An artist's rendering of the Ultium Cells battery cell production facility to be built in Spring Hill, Tennessee, which will employ 1,300 people. Recognizing the unique expertise of their organizations, ORNL, TVA, and the Tennessee Department of Economic and Community Development have been working together for several years to bring startups developing battery technologies for EVs and established automotive firms to Tennessee. Credit: Ultium Cells](/sites/default/files/styles/list_page_thumbnail/public/2022-02/UltiumCellsLLC-SpringHill-TN-Rendering_0.jpg?h=f9f6f138&itok=_TJq1Ajl)
ORNL, TVA and TNECD were recognized by the Federal Laboratory Consortium for their impactful partnership that resulted in a record $2.3 billion investment by Ultium Cells, a General Motors and LG Energy Solution joint venture, to build a battery cell manufacturing plant in Spring Hill, Tennessee.
![Belinda Akpa applies her diverse expertise and high-performance computing to accelerate the drug discovery process and increase the chances of success when candidate molecules go to clinical trials. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02772_1.jpg?h=0a8b6f8b&itok=seLu5znj)
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
![Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02194_small.jpg?h=c6980913&itok=bc6MRBX6)
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
![Analyses of lung fluid cells from COVID-19 patients conducted on the nation’s fastest supercomputer point to gene expression patterns that may explain the runaway symptoms produced by the body’s response to SARS-CoV-2. Credit: Jason B. Smith/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-07/cells%20200%5B1%5D.png?h=b95f6d72&itok=V2OxqL5l)
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.
![Omar Demerdash](/sites/default/files/styles/list_page_thumbnail/public/2020-05/demerdash_crop.jpg?h=8831409f&itok=2J2gUqDr)
With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.